These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333 [Abstract] [Full Text] [Related]
28. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. Gennari L, Becherini L, Mansani R, Masi L, Falchetti A, Morelli A, Colli E, Gonnelli S, Cepollaro C, Brandi ML. J Bone Miner Res; 1999 Aug; 14(8):1379-86. PubMed ID: 10457270 [Abstract] [Full Text] [Related]
31. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer. Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C. Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252 [Abstract] [Full Text] [Related]
32. Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study. Tofteng CL, Jensen JE, Abrahamsen B, Odum L, Brot C. J Bone Miner Res; 2002 Aug 20; 17(8):1535-44. PubMed ID: 12162507 [Abstract] [Full Text] [Related]
33. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss. Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black DM, Kuller LH. J Bone Miner Res; 2000 Feb 20; 15(2):308-14. PubMed ID: 10703933 [Abstract] [Full Text] [Related]
37. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women. Salmen T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH. Ann Med; 2003 Feb 20; 35(4):282-8. PubMed ID: 12846271 [Abstract] [Full Text] [Related]
38. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women. Erdogan MO, Yıldız H, Artan S, Solak M, Taşcıoğlu F, Dündar U, Eser B, Colak E. Osteoporos Int; 2011 Apr 20; 22(4):1219-25. PubMed ID: 20532479 [Abstract] [Full Text] [Related]
40. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK. J Clin Endocrinol Metab; 1997 Apr 20; 82(4):991-5. PubMed ID: 9100562 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]